Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Annual TAVR procedures among patients younger than 70 rose from 15 in 2014 to 134 in 2024 within one health system, driven primarily by patients in their 60s, while surgery remained predominant.
Annual TAVR procedures among patients younger than 70 rose from 15 in 2014 to 134 in 2024 within one health system, driven primarily by patients in their 60s, while surgery remained predominant.
Post-hoc analysis presented by Dr. Sripal Bangalore also found reaching lower lobes of lungs was associated with greater hemodynamic restoration without added safety concerns.
Post-hoc analysis presented by Dr. Sripal Bangalore also found reaching lower lobes of lungs was associated with greater hemodynamic restoration without added safety concerns.
Anteris Technologies Global Corp. announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492...
Anteris Technologies Global Corp. announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492...
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
